Patents by Inventor Nicholas T. Hertz

Nicholas T. Hertz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11427588
    Abstract: Disclosed herein inter alia are compositions and methods useful in the treatment neurodegenerative diseases and cardiomyopathy, and for modulating the activity of PINK1.
    Type: Grant
    Filed: May 26, 2020
    Date of Patent: August 30, 2022
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, MITOKININ, INC.
    Inventors: Nicholas T. Hertz, Kevan M. Shokat, Robert DeVita
  • Publication number: 20220054489
    Abstract: Disclosed herein inter alia are compositions and methods useful in the treatment of cancer and for modulating the activity of Aurora A kinase and/or a Myc family protein.
    Type: Application
    Filed: August 30, 2021
    Publication date: February 24, 2022
    Inventors: Justin Gabriel Meyerowitz, William Clay Gustafson, William A. Weiss, Nicholas T. Hertz, Kevan M. Shokat
  • Patent number: 11135222
    Abstract: Disclosed herein inter alia are compositions and methods useful in the treatment of cancer and for modulating the activity of Aurora A kinase and/or a Myc family protein.
    Type: Grant
    Filed: November 20, 2015
    Date of Patent: October 5, 2021
    Assignee: THE REGENTS OF THE UNIVERSIITY OF CALIFORNIA
    Inventors: Justin Gabriel Meyerowitz, William Clay Gustafson, William A. Weiss, Nicholas T. Hertz, Kevan M. Shokat
  • Publication number: 20200283442
    Abstract: Disclosed herein inter alia are compositions and methods useful in the treatment neurodegenerative diseases and cardiomyopathy, and for modulating the activity of PINK 1.
    Type: Application
    Filed: May 26, 2020
    Publication date: September 10, 2020
    Inventors: Nicholas T. Hertz, Kevan M. Shokat, Robert DeVita
  • Patent number: 10723737
    Abstract: Disclosed herein inter alia are compositions and methods useful in the treatment neurodegenerative diseases and cardiomyopathy, and for modulating the activity of PINK1.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: July 28, 2020
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, MITOKININ LLC
    Inventors: Nicholas T. Hertz, Kevan M. Shokat, Robert DeVita
  • Publication number: 20180072731
    Abstract: Disclosed herein inter alia are compositions and methods useful in the treatment neurodegenerative diseases and cardiomyopathy, and for modulating the activity of PINK1.
    Type: Application
    Filed: February 21, 2017
    Publication date: March 15, 2018
    Inventors: Nicholas T. Hertz, Kevan M. Shokat, Robert DeVita
  • Publication number: 20160250211
    Abstract: Disclosed herein inter alia are compositions and methods useful in the treatment of cancer and for modulating the activity of Aurora A kinase and/or a Myc family protein.
    Type: Application
    Filed: November 20, 2015
    Publication date: September 1, 2016
    Inventors: Justin Gabriel Meyerowitz, William Clay Gustafson, William A. Weiss, Nicholas T. Hertz, Kevan M. Shokat
  • Publication number: 20160108044
    Abstract: Disclosed herein inter alia are compositions and methods useful in the treatment neurodegenerative diseases and cardiomyopathy, and for modulating the activity of PINK1.
    Type: Application
    Filed: August 11, 2015
    Publication date: April 21, 2016
    Inventors: Nicholas T. Hertz, Kevan M. Shokat, Robert DeVita